In PCa and its highly aggressive variant neuroendocrine PCa (NEPC) (Davies et al., 2018), which expresses elevated H19 levels as compared to adenocarcinoma (Ramnarine et al. The gene discussed is H19; the disease is posterior cortical atrophy.